Agrylin Oral Capsule 0.5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Agrylin: Oral capsule (0.5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_4860.JPG
Agrylin 0.5mg Cap
Shire US Inc
Pill Identification: LOGO 063,ROBERTS 063 
Drug Image file DrugItem_3363.JPG
Agrylin 0.5mg Cap
Shire US Inc
Pill Identification: LOGO 063,ROBERTS 063 
Drug Image file DrugItem_6304.JPG
Anagrelide 0.5mg Cap
Mallinckrodt Inc Pharmaceuticals Group
Pill Identification: M 0.5 mg 
Drug Image file DrugItem_17379.JPG
Anagrelide 0.5mg Cap
Ivax Pharmaceuticals Inc a Division of Teva USA
Pill Identification: LOGO 5241 0.5 mg 
Drug Image file DrugItem_7441.JPG
Anagrelide 0.5mg Cap
Mylan Pharmaceuticals Inc
Pill Identification: MYLAN 6868 MYLAN 6868 
Drug Image file DrugItem_8056.JPG
Anagrelide 0.5mg Cap
Barr Laboratories Inc a Division of Teva USA
Pill Identification: barr 0.5mg 101 

What is this Medicine?

ANAGRELIDE (an AG re lide) is used to lower platelet counts. This helps to prevent blood clots from forming. It also reduces the risk of problems like intestinal bleeding, stroke, and heart attack caused by having too many platelets.

In-Depth Information

Agrylin 0.5mg Capsule

NDC: 540920063
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Polycythemia Vera, Thrombocytosis, Chronic Myelogenous Leukemia (CML)

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Agrylin 0.5mg Capsule
Drug Image file DrugItem_4860.JPG
Shire US Inc
Pill Identification: LOGO 063,ROBERTS 063 
Shape: capsule
Color: white
Drug Image file DrugItem_3363.JPG
Shire US Inc
Pill Identification: LOGO 063,ROBERTS 063 
Shape: capsule
Color: white

Reported Side Effects for Agrylin 0.5mg Capsule

Abnormal Heart Rhythm Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Loss Of Memory Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Fainting Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Muscle Cramps Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Blood In The Urine Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Intestinal Bleeding Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Bleeding Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Rapid Heart Rate Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Ringing In Ears Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Low Platelet Count Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Sinus Infection Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Visual Impairment Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Blood Clot Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Rhinitis Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Kidney Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Photosensitivity Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Peripheral Vasodilation Incidence:
<5.0%*
Severity: MODERATE
Onset: RAPID
Melena Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Enlarged Lymph Nodes Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Hypoesthesia Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Belching Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Bruise Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Double Vision Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Confusion Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Chills Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Chest Pain Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Joint Pain Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Constipation Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Dehydration Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Depression Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Anemia Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Painful Urination Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Lazy Eye Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Hair Loss Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Nose Bleed Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Inflamed Stomach Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Postural Low Blood Pressure Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Muscle Pain Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Migraine Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Inability To Sleep Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Heart Failure Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
5.2%*
Severity: MILD
Onset: EARLY
Itching Incidence:
5.5%*
Severity: MILD
Onset: RAPID
Back Pain Incidence:
5.9%*
Severity: MILD
Onset: DELAYED
Paresthesias Incidence:
5.9%*
Severity: MILD
Onset: DELAYED
Cough Incidence:
6.3%*
Severity: MILD
Onset: DELAYED
Feeling Sick Incidence:
6.4%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
6.8%*
Severity: MILD
Onset: DELAYED
Rapid Heart Rate Incidence:
7.5%*
Severity: MODERATE
Onset: RAPID
Decreased Appetite Incidence:
7.7%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
8.3%*
Severity: MILD
Onset: EARLY
Hives Incidence:
8.3%*
Severity: MILD
Onset: RAPID
Fluid Retention Incidence:
8.5%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
8.9%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
9.7%*
Severity: MILD
Onset: EARLY
Gas Incidence:
10.2%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
11.9%*
Severity: MODERATE
Onset: EARLY
Lightheadedness Incidence:
15.4%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
16.4%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
17.1%*
Severity: MILD
Onset: EARLY
Swelling Incidence:
20.6%*
Severity: MODERATE
Onset: DELAYED
Weakness Incidence:
23.1%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
25.7%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
26.1%*
Severity: MODERATE
Onset: EARLY
Headache Incidence:
43.5%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Agrylin 0.5mg Capsule

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Caffeine-containing Foods/Beverages and Agrylin 0.5mg Capsule(Anagrelide Hydrochloride)
Caffeine-containing Foods/Beverages and Anagrelide Hydrochloride(Anagrelide Hydrochloride)
Although an interaction is possible, these drugs can be taken together. Theoretically, side effects from Caffeine may get worse if you take Anagrelide. Too much Caffeine can cause effects like nausea, nervousness, or sleeplessness. You may need to limit your Caffeine intake. Common foods and beverages containing caffeine include coffee, teas, colas and chocolate. Many non-prescription drugs and diet aids may also contain caffeine.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Agrylin

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5